These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27036581)

  • 1. Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas.
    Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
    Med Phys; 2016 Apr; 43(4):1841. PubMed ID: 27036581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy.
    Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
    Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy for non-malignant shoulder syndrome: Is there a risk for radiation-induced carcinogenesis?
    Mazonakis M; Lyraraki E; Tzedakis A; Damilakis J
    Phys Med; 2017 Nov; 43():73-78. PubMed ID: 29195566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ-specific radiation-induced cancer risk estimates due to radiotherapy for benign pigmented villonodular synovitis.
    Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
    Phys Med Biol; 2016 Sep; 61(17):6400-12. PubMed ID: 27499236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy for stage I seminoma of the testis: Organ equivalent dose to partially in-field structures and second cancer risk estimates on the basis of a mechanistic, bell-shaped, and plateau model.
    Mazonakis M; Varveris C; Lyraraki E; Damilakis J
    Med Phys; 2015 Nov; 42(11):6309-16. PubMed ID: 26520723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Out-of-field organ doses and associated radiogenic risks from para-aortic radiotherapy for testicular seminoma.
    Mazonakis M; Berris T; Varveris C; Lyraraki E; Damilakis J
    Med Phys; 2014 May; 41(5):051702. PubMed ID: 24784368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second cancer risk assessments after involved-site radiotherapy for mediastinal Hodgkin lymphoma.
    Mazonakis M; Lyraraki E; Damilakis J
    Med Phys; 2017 Jul; 44(7):3866-3874. PubMed ID: 28493609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probability of carcinogenesis due to involved field and involved site radiation therapy techniques for supra- and infradiaphragmatic Hodgkin's disease.
    Kourinou KM; Mazonakis M; Lyraraki E; Papadaki HΑ; Damilakis J
    Phys Med; 2019 Jan; 57():100-106. PubMed ID: 30738513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk estimates from radiation therapy for heterotopic ossification prophylaxis after total hip arthroplasty.
    Mazonakis M; Berris T; Lyraraki E; Damilakis J
    Med Phys; 2013 Oct; 40(10):101702. PubMed ID: 24089892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral organ doses from radiotherapy for heterotopic ossification of non-hip joints: is there a risk for radiation-induced malignancies?
    Berris T; Mazonakis M; Kachris S; Damilakis J
    Phys Med; 2014 May; 30(3):309-13. PubMed ID: 24084192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2-dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer.
    Joosten A; Bochud F; Moeckli R
    Phys Med Biol; 2014 Aug; 59(16):4697-722. PubMed ID: 25082795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
    Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
    Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field.
    Paganetti H; Athar BS; Moteabbed M; A Adams J; Schneider U; Yock TI
    Phys Med Biol; 2012 Oct; 57(19):6047-61. PubMed ID: 22968191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SECOND CANCER RISK FROM RADIATION THERAPY FOR COMMON SOLID TUMORS DIAGNOSED IN REPRODUCTIVE-AGED FEMALES.
    Mazonakis M; Kachris S; Damilakis J
    Radiat Prot Dosimetry; 2018 Dec; 182(2):208-214. PubMed ID: 29608744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening computed tomography colonography with 256-slice scanning: should patient radiation burden and associated cancer risk constitute a major concern?
    Perisinakis K; Seimenis I; Tzedakis A; Papadakis AE; Kourinou KM; Damilakis J
    Invest Radiol; 2012 Aug; 47(8):451-6. PubMed ID: 22766908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.
    Candela-Juan C; Perez-Calatayud J; Ballester F; Rivard MJ
    Med Phys; 2013 Mar; 40(3):033901. PubMed ID: 23464344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of lifetime attributable risks (LARs) of cancer associated with abdominopelvic radiotherapy treatment planning computed tomography (CT) simulations.
    Bagherzadeh S; Jabbari N; Khalkhali HR
    Int J Radiat Biol; 2018 May; 94(5):454-461. PubMed ID: 29528791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple-rule-out computed tomography angiography with 256-slice computed tomography scanners: patient-specific assessment of radiation burden and associated cancer risk.
    Perisinakis K; Seimenis I; Tzedakis A; Papadakis AE; Damilakis J
    Invest Radiol; 2012 Feb; 47(2):109-15. PubMed ID: 21857528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.
    Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M
    J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of contralateral breast and ipsilateral lung cancer induction from forward-planned IMRT for breast carcinoma.
    Mazonakis M; Stratakis J; Lyraraki E; Damilakis J
    Phys Med; 2019 Apr; 60():44-49. PubMed ID: 31000085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.